Company / Capital Expenditures
Day One Biopharmaceuticals, Inc. Capital Expenditures History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$320.0K
FY2025
5-year range
$0 / $2.2M
FY2021-FY2025
Trend
-85.2%
vs FY2024
Sector context
#145 of 192
Health Care
What the data says
Day One Biopharmaceuticals, Inc.'s capital expenditures of $320,000 is lower than 76% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 7 years, ranging from $0 in FY2021 to $2M in FY2024.
Based on SEC 10-K filings.
$320,000 in FY2025 with a 5-year CAGR of +28.3%.
Improved from $224,000 to $320,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +130.9%
- 5-Year CAGR
- +28.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 192This company $320.0K Sector average $118.6M
▼
-99.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +28.3%, indicating consistent growth.
- In FY2025, capital expenditures decreased 85.2% year-over-year.
- Ranks #145 out of 192 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $320.0K | -85.2% |
| FY2024 | $2.2M | +868.3% |
| FY2023 | $224.0K | +761.5% |
| FY2022 | $26.0K | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $92.0K | - |
| FY2019 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026